BREAKING: In surprise reversal, Sarepta $SRPT says it will pause shipments of Duchenne gene therapy statnews.com/2025/07/21/sar… via Jason Mast and me

Latest: A race to develop a new class of narcolepsy drugs could not only transform treatment for patients with the rare sleep disorder, but also many people with common health conditions like Alzheimer's and depression who struggle to stay awake. statnews.com/2025/07/22/nar…

SCOOP from Adam Feuerstein ✡️, Jason Mast: Sarepta’s Duchenne therapy faces an "arduous" path back to market, a senior FDA official says, suggesting the treatment’s license could be revoked statnews.com/2025/07/22/fda…

On this week's podcast: we bring on the mother of a boy with Duchenne muscular dystrophy to talk about the impact of Sarepta's gene therapy halt. w/ Adam Feuerstein ✡️, Allison DeAngelis statnews.com/2025/07/24/rea…

BREAKING: Vinay Prasad departs the FDA Lizzy Lawrence Adam Feuerstein ✡️ Matthew Herper statnews.com/2025/07/29/vin…

🚨 The Trump administration has blocked the NIH from awarding any research grants and contracts. Via STAT statnews.com/2025/07/29/tru…

Inside the fall of Vinay Prasad at the FDA How a powerful and extremely online regulator ran out of friends when it mattered most from Lizzy Lawrence statnews.com/2025/07/30/vin…

Revealing piece from Casey Ross John Wilkerson: MAGA influencers take a sudden interest in Medicare Advantage reforms, echoing a dark money group statnews.com/2025/08/01/mag… via STAT

Eli Lilly’s $LLY much-anticipated obesity pill yields modest results Orforglipron led to 11% weight loss in late-stage trial, short of Zepbound and Wegovy statnews.com/2025/08/07/eli… via Elaine Chen

BREAKING: Vinay Prasad returns to the FDA via Lizzy Lawrence statnews.com/2025/08/09/vin…

Interesting that Viking Therapeutics' CEO is among the top-paid execs in the health care industry. He got a bigger pay package last year than AbbVie's CEO -- via STAT's annual health care CEO compensation report from Bob Herman, J Emory Parker is on BlueSky statnews.com/2025/08/18/hea…

Latest — Pharma has enthusiastically supported one of Trump's demands to lower prices: selling drugs directly to consumers. The reality, though, is that doing this is unlikely to make drugs much more affordable, if at all. statnews.com/2025/08/19/dir…

We think of AI as something that decreases costs and increases revenue. But _for whom_ does it make more $? AI scribe companies promise doctors will get paid for everything they did. But where is that $ coming from? All of us. More from me STAT: statnews.com/2025/08/20/ai-…

News: The man who attacked the CDC in a shooting earlier this month attempted to enter its campus days earlier, investigators believe statnews.com/2025/08/21/cdc…

MAHA turned 1 over the weekend, and it's hard to believe it's only been one year since Kennedy endorsed Trump and kickstarted this movement. I talked with nearly two dozen people to try and make sense of all that has happened — or not. statnews.com/2025/08/25/rfk…

Under RFK Jr. and his aides, the U.S. has seen a big shift on recommendations for Covid vaccines. Another big shift — particularly when it comes childhood vaccines — is likely to get underway in about two weeks. Via Elaine Chen statnews.com/2025/09/03/chi…

I took a trip up to a Pa. farmers market where even the poorest shoppers could get gleaming ears of corn, muscular tomatoes & fresh bread. To MAHA, this is the ultimate pharmacy. But federal programs that put it within reach for many are now facing cuts. statnews.com/2025/09/03/wha…

For two days, RFK Jr.’s handpicked panel of vaccine advisors deliberated over Covid vaccines, delaying hep B shots for kids, and more, ultimately moving the needle towards restricting proven shots. Here’s what went down: (with Elaine Chen & Lizzy Lawrence) statnews.com/2025/09/19/wha…